Literature DB >> 25436139

A case of periampullary adenocarcinoma in neurofibromatosis type 1.

C Andrew Kistler1, Jennifer M Johnson1, Jordan M Winter1, Jeffrey P Baliff1, Ali A Siddiqui1, Ashwin R Sama1.   

Abstract

Neurofibromatosis type 1 (NF-1) is an autosomal dominant genetic disorder with a known predisposition to gastrointestinal neoplasms such as stromal tumors and carcinoids. Adenocarcinomas (ACs) of the gastrointestinal tract are relatively rare in patients with NF-1, especially those found in the periampullary region. We present a case report of periampullary adenocarcinoma in a 56-year-old woman with NF-1 who presented with abdominal pain and obstructive jaundice.

Entities:  

Keywords:  Periampullary adenocarcinoma (AC); neurofibromatosis type 1 (NF-1)

Year:  2014        PMID: 25436139      PMCID: PMC4226813          DOI: 10.3978/j.issn.2078-6891.2014.047

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  12 in total

1.  Neurofibromatosis and small bowel adenocarcinoma: an unrecognised association.

Authors:  T J Jones; T L Marshall
Journal:  Gut       Date:  1987-09       Impact factor: 23.059

2.  Tumors of ampulla of Vater: A case series and review of chemotherapy options.

Authors:  Adriana Romiti; Viola Barucca; Angelo Zullo; Ida Sarcina; Roberta Di Rocco; Chiara D'Antonio; Marco Latorre; Paolo Marchetti
Journal:  World J Gastrointest Oncol       Date:  2012-03-15

Review 3.  Periampullary and duodenal neoplasms in neurofibromatosis type 1: two cases and an updated 20-year review of the literature yielding 76 cases.

Authors:  Daniel Relles; Jennie Baek; Agnieszka Witkiewicz; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2010-03-19       Impact factor: 3.452

Review 4.  Tumor microenvironment and neurofibromatosis type I: connecting the GAPs.

Authors:  L Q Le; L F Parada
Journal:  Oncogene       Date:  2007-02-12       Impact factor: 9.867

Review 5.  Primary duodenal adenocarcinoma associated with neurofibromatosis type 1.

Authors:  Young-Eun Joo; Hyun-Soo Kim; Sung-kyu Choi; Jong-Sun Rew; Chang-Soo Park; Sei-Jong Kim
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

Review 6.  Ampullary adenocarcinoma in neurofibromatosis type 1. Case report and literature review.

Authors:  R Costi; P Caruana; L Sarli; V Violi; L Roncoroni; C Bordi
Journal:  Mod Pathol       Date:  2001-11       Impact factor: 7.842

Review 7.  Periampullary neoplasms in von Recklinghausen's disease.

Authors:  A Klein; J Clemens; J Cameron
Journal:  Surgery       Date:  1989-11       Impact factor: 3.982

8.  Molecular analysis of PIK3CA, BRAF, and RAS oncogenes in periampullary and ampullary adenomas and carcinomas.

Authors:  Frank Schönleben; Wanglong Qiu; John D Allendorf; John A Chabot; Helen E Remotti; Gloria H Su
Journal:  J Gastrointest Surg       Date:  2009-05-14       Impact factor: 3.452

9.  Prognostic significance of AKT/mTOR and MAPK pathways and antitumor effect of mTOR inhibitor in NF1-related and sporadic malignant peripheral nerve sheath tumors.

Authors:  Makoto Endo; Hidetaka Yamamoto; Nokitaka Setsu; Kenichi Kohashi; Yusuke Takahashi; Takeaki Ishii; Kei-ichiro Iida; Yoshihiro Matsumoto; Michiyuki Hakozaki; Mikiko Aoki; Hiroshi Iwasaki; Yoh Dobashi; Kenichi Nishiyama; Yukihide Iwamoto; Yoshinao Oda
Journal:  Clin Cancer Res       Date:  2012-12-03       Impact factor: 12.531

10.  Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial.

Authors:  John P Neoptolemos; Malcolm J Moore; Trevor F Cox; Juan W Valle; Daniel H Palmer; Alexander C McDonald; Ross Carter; Niall C Tebbutt; Christos Dervenis; David Smith; Bengt Glimelius; Richard M Charnley; François Lacaine; Andrew G Scarfe; Mark R Middleton; Alan Anthoney; Paula Ghaneh; Christopher M Halloran; Markus M Lerch; Attila Oláh; Charlotte L Rawcliffe; Caroline S Verbeke; Fiona Campbell; Markus W Büchler
Journal:  JAMA       Date:  2012-07-11       Impact factor: 56.272

View more
  2 in total

1.  Synchronous neuroendocrine tumor and non-small-cell lung cancer in neurofibromatosis type 1.

Authors:  Andrew Hsu; Samuel Han
Journal:  Clin Case Rep       Date:  2015-11-01

2.  Intraductal papillary bile duct adenocarcinoma and gastrointestinal stromal tumor in a case of neurofibromatosis type 1.

Authors:  Jung Min Lee; Jae Min Lee; Jong Jin Hyun; Hyuk Soon Choi; Eun Sun Kim; Bora Keum; Yoon Tae Jeen; Hoon Jai Chun; Hong Sik Lee; Chang Duck Kim; Dong Sik Kim; Joo Young Kim
Journal:  World J Gastroenterol       Date:  2018-01-28       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.